Home › Cancro alla prostata › Montana
Studi clinici su Cancro alla prostata nello stato di Montana
17 studi su Cancro alla prostata cercano partecipanti presso sedi nello stato di Montana.
Città nello stato di Montana
Testo ufficiale dello studio (inglese)
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
- Community Hospital of Anaconda, Anaconda
- Billings Clinic Cancer Center, Billings
- Saint Vincent Frontier Cancer Center, Billings
- e altri 4
In reclutamentoFase 3
Età 18 e oltre · Uomini · Aggiornato il 2 ott 2026 · NCT06931340Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial
- Billings Clinic Cancer Center, Billings
- Bozeman Health Deaconess Hospital, Bozeman
- Benefis Sletten Cancer Institute, Great Falls
- e altri 1
In reclutamentoFase 3
Età 18 e oltre · Uomini · Aggiornato il 2 ott 2026 · NCT07200830Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Community Hospital of Anaconda, Anaconda
- Billings Clinic Cancer Center, Billings
- Bozeman Health Deaconess Hospital, Bozeman
- e altri 7
In reclutamentoStudio osservazionaleVolontari sani benvenuti
Età da 40 a 75 · Tutti i sessi · Aggiornato il 2 ott 2026 · NCT05334069Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
- Billings Clinic Cancer Center, Billings
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 2 ott 2026 · NCT06632977Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
- Community Hospital of Anaconda, Anaconda
- Billings Clinic Cancer Center, Billings
- Bozeman Health Deaconess Hospital, Bozeman
- e altri 3
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 30 set 2026 · NCT03866382A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
- St. Vincent Frontier Cancer Center-Research ( Site 0037), Billings
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 25 set 2026 · NCT06136650A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
- St. Vincent Frontier Cancer Center-Research ( Site 0037), Billings
In reclutamentoFase 3
Età 18 e oltre · Uomini · Aggiornato il 17 set 2026 · NCT06925737Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
- Billings Clinic Cancer Center, Billings
- Benefis Sletten Cancer Institute, Great Falls
- Hi-Line Sletten Cancer Center, Havre
In reclutamentoFase 3
Età 18 e oltre · Uomini · Aggiornato il 10 set 2026 · NCT05946213Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
- Billings Clinic Cancer Center, Billings
- Bozeman Health Deaconess Hospital, Bozeman
- Benefis Sletten Cancer Institute, Great Falls
- e altri 5
In reclutamentoFase 3
Età 18 e oltre · Uomini · Aggiornato il 19 ago 2026 · NCT04423211Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
- Community Hospital of Anaconda, Anaconda
- Billings Clinic Cancer Center, Billings
- Bozeman Health Deaconess Hospital, Bozeman
- e altri 7
In reclutamentoFase 3
Età 18 e oltre · Uomini · Aggiornato il 14 lug 2026 · NCT06592924Integrated Cancer Repository for Cancer Research
- Bozeman Health Deaconess Hospital, Bozeman
In reclutamentoStudio osservazionaleVolontari sani benvenuti
Età da 19 a 110 · Tutti i sessi · Aggiornato il 29 giu 2026 · NCT02012699Androgen Suppression Combined With Nodal Irradiation and Dose Escalated Prostate Treatment
- Billings Clinic Cancer Center, Billings
In reclutamentoFase 3
Età 18 e oltre · Uomini · Aggiornato il 14 apr 2026 · NCT06235697Telehealth Exercise Program Evaluating Fatigue and Physical Function in Rural Cancer Survivors
- University of Montana, Missoula
In reclutamentoFase 2
Età da 18 a 89 · Tutti i sessi · Aggiornato il 5 feb 2026 · NCT07001241Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation
- Community Hospital of Anaconda, Anaconda
- Billings Clinic Cancer Center, Billings
- Bozeman Deaconess Hospital, Bozeman
- e altri 4
In reclutamentoFase 2
Età 18 e oltre · Uomini · Aggiornato il 29 gen 2026 · NCT05806515Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body
- Community Hospital of Anaconda, Anaconda
- Billings Clinic Cancer Center, Billings
- Bozeman Health Deaconess Hospital, Bozeman
- e altri 4
In reclutamentoFase 3
Età 18 e oltre · Uomini · Aggiornato il 22 gen 2026 · NCT06470243SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Billings
In reclutamentoStudio osservazionale
Tutte le età · Tutti i sessi · Aggiornato il 28 ott 2025 · NCT03452774Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
- Billings Clinic Cancer Center, Billings
- Bozeman Deaconess Hospital, Bozeman
- Saint James Community Hospital and Cancer Treatment Center, Butte
- e altri 2
In reclutamentoFase 3
Età 18 e oltre · Uomini · Aggiornato il 11 set 2025 · NCT03678025Fonte: ClinicalTrials.gov, dati recuperati il 5 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.